Leucine-rich repeat kinase 2 biomarkers for Parkinson's disease

被引：0

作者：

Dzamko, Nicolas ^{[1
]}

机构：

[1] Univ Sydney, Fac Med & Hlth, Brain & Mind Ctr, Camperdown, NSW, Australia

来源：

BIOCHEMICAL JOURNAL | 2025年 / 482卷 / 11期

关键词：

MITOCHONDRIAL-DNA DAMAGE; RAB10; PHOSPHORYLATION; ALPHA-SYNUCLEIN; LRRK2; MUTATIONS; BIS(MONOACYLGLYCEROL)PHOSPHATE; EXOSOMES; MONITOR; CELLS; GENE;

D O I：

10.1042/bcj20253099

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Leucine-rich repeat kinase 2 (LRRK2) has emerged as a promising therapeutic target for the treatment of neurodegenerative Parkinson's disease (PD). Data from a multitude of pre-clinical models are supportive of a potential role for LRRK2 therapies to ameliorate cellular dysfunctions found in PD, and small molecules to inhibit LRRK2 kinase activity, as well as antisense oligonucleotides to target the protein itself, are in clinical trials. Despite this, exactly how LRRK2 contributes to PD pathogenesis remains to be determined, and definitive biomarkers to track LRRK2 function are still required. Such biomarkers can be useful for monitoring the pharmacodynamic response of LRRK2 therapeutics and/or understanding the relationship between LRRK2 and the clinical progression of PD. Moreover, biomarkers that can identify increased LRRK2 levels or activity beyond just carriers of pathogenic LRRK2 mutations will be important for expanding LRRK2 therapeutics to other PD populations. This review summarizes recent findings regarding biomarkers of LRRK2.

引用

页码：711 / 722

页数：12

共 98 条

[1] Higher Urine bis(Monoacylglycerol)Phosphate Levels in LRRK2 G2019S Mutation Carriers: Implications for Therapeutic Development [J].

Alcalay, Roy N. ;

Hsieh, Frank ;

Tengstrand, Elizabeth ;

Padmanabhan, Shalini ;

Baptista, Marco ;

Kehoe, Caitlin ;

Narayan, Sushma ;

Boehme, Amelia K. ;

Merchant, Kalpana .

MOVEMENT DISORDERS, 2020, 35 (01) :134-141

[2] LRRK2-mediated Rab10 phosphorylation in immune cells from Parkinson's disease patients [J].

Atashrazm, Farzaneh ;

Hammond, Deborah ;

Perera, Gayathri ;

Bolliger, Marc F. ;

Matar, Elie ;

Halliday, Glenda M. ;

Schule, Birgitt ;

Lewis, Simon J. G. ;

Nichols, R. Jeremy ;

Dzamko, Nicolas .

MOVEMENT DISORDERS, 2019, 34 (03) :406-415

[3] Primary cilia mediate mitochondrial stress responses to promote dopamine neuron survival in a Parkinson's disease model [J].

Bae, Ji-Eun ;

Kang, Gil Myung ;

Min, Se Hee ;

Jo, Doo Sin ;

Jung, Yong-Keun ;

Kim, Keetae ;

Kim, Min-Seon ;

Cho, Dong-Hyung .

CELL DEATH & DISEASE, 2019, 10 (12)

[4] LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficits [J].

Baptista, Marco A. S. ;

Merchant, Kalpana ;

Barrett, Ted ;

Bhargava, Sakshi ;

Bryce, Dianne K. ;

Ellis, J. Michael ;

Estrada, Anthony A. ;

Fell, Matthew J. ;

Fiske, Brian K. ;

Fuji, Reina N. ;

Galatsis, Paul ;

Henry, Anastasia G. ;

Hill, Sue ;

Hirst, Warren ;

Houle, Christopher ;

Kennedy, Matthew E. ;

Liu, Xingrong ;

Maddess, Matthew L. ;

Markgraf, Carrie ;

Mei, Hong ;

Meier, William A. ;

Needle, Elie ;

Ploch, Stephen ;

Royer, Christopher ;

Rudolph, Karin ;

Sharma, Alok K. ;

Stepan, Antonia ;

Steyn, Stefan ;

Trost, Craig ;

Yin, Zhizhang ;

Yu, Hongshi ;

Wang, Xiang ;

Sherer, Todd B. .

SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (540)

[5] LRRK2 mediates tubulation and vesicle sorting from lysosomes [J].

Bonet-Ponce, Luis ;

Beilina, Alexandra ;

Williamson, Chad D. ;

Lindberg, Eric ;

Kluss, Jillian H. ;

Saez-Atienzar, Sara ;

Landeck, Natalie ;

Kumaran, Ravindran ;

Mamais, Adamantios ;

Bleck, Christopher K. E. ;

Li, Yan ;

Cookson, Mark R. .

SCIENCE ADVANCES, 2020, 6 (46)

[6] Staging of brain pathology related to sporadic Parkinson's disease [J].

Braak, H ;

Del Tredici, K ;

Rüb, U ;

de Vos, RAI ;

Steur, ENHJ ;

Braak, E .

NEUROBIOLOGY OF AGING, 2003, 24 (02) :197-211

[7] Loss of mitochondrial Ca2+ response and CaMKII/ERK activation by LRRK2R1441G mutation correlate with impaired depolarization-induced mitophagy [J].

Chang, Eunice Eun-Seo ;

Liu, Huifang ;

Choi, Zoe Yuen-Kiu ;

Malki, Yasine ;

Zhang, Steffi Xi-Yue ;

Pang, Shirley Yin-Yu ;

Kung, Michelle Hiu-Wai ;

Ramsden, David B. ;

Ho, Shu-Leong ;

Ho, Philip Wing-Lok .

CELL COMMUNICATION AND SIGNALING, 2024, 22 (01)

[8] Phosphorylation of LRRK2 by casein kinase 1α regulates trans-Golgi clustering via differential interaction with ARHGEF7 [J].

Chia, Ruth ;

Haddock, Sara ;

Beilina, Alexandra ;

Rudenko, Iakov N. ;

Mamais, Adamantios ;

Kaganovich, Alice ;

Li, Yan ;

Kumaran, Ravindran ;

Nalls, Michael A. ;

Cookson, Mark R. .

NATURE COMMUNICATIONS, 2014, 5

[9] A pathway for Parkinson's Disease LRRK2 kinase to block primary cilia and Sonic hedgehog signaling in the brain [J].

Dhekne, Herschel S. ;

Yanatori, Izumi ;

Gomez, Rachel C. ;

Tonelli, Francesca ;

Diez, Federico ;

Schule, Birgitt ;

Steger, Martin ;

Alessi, Dario R. ;

Pfeffer, Suzanne R. .

ELIFE, 2018, 7

[10] LRRK2 activation in idiopathic Parkinson's disease [J].

Di Maio, Roberto ;

Hoffman, Eric K. ;

Rocha, Emily M. ;

Keeney, Matthew T. ;

Sanders, Laurie H. ;

De Miranda, Briana R. ;

Zharikov, Alevtina ;

Van Laar, Amber ;

Stepan, Antonia F. ;

Lanz, Thomas A. ;

Kofler, Julia K. ;

Burton, Edward A. ;

Alessi, Dario R. ;

Hastings, Teresa G. ;

Greenamyre, J. Timothy .

SCIENCE TRANSLATIONAL MEDICINE, 2018, 10 (451)

← 1 2 3 4 5 6 7 8 9 10 →